Method for selective ablation of undifferentiated human pluripotent stem cell populations for cell-based therapies-Reference-Cited by-同舟云学术

Method for selective ablation of undifferentiated human pluripotent stem cell populations for cell-based therapies

Published:2021-04-08 Issue:7 Volume:6 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Chour Tony^ORCID,Tian Lei^ORCID,Lau Edward^ORCID,Thomas Dilip^ORCID,Itzhaki Ilanit,Malak Olfat,Zhang Joe Z.,Qin Xulei,Wardak Mirwais^ORCID,Liu Yonggang,Chandy Mark^ORCID,Black Katelyn E.,Lam Maggie P.Y.,Neofytou Evgenios,Wu Joseph C.^ORCID

Funder

National Institutes of Health

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/142000/files/pdf

Reference40 articles.

1. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors

2. Cardiac cell therapy: Current status, challenges and perspectives

3. Cozzarelli Prize Winner: Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling

4. Stem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies

5. Improving cell engraftment in cardiac stem cell therapy;Li;Stem Cells Int,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorting differentiated mammalian cells using deterministic lateral displacement microfluidic devices;Analytical Sciences;2024-07-26

2. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications;Signal Transduction and Targeted Therapy;2024-04-26

3. Stem cell‑mediated modulation of pyroptosis contributes to tissue repair in noninfective inflammatory‑related diseases (Review);International Journal of Molecular Medicine;2024-03-29

4. Stem cell-based therapy in cardiac repair after myocardial infarction: Promise, challenges, and future directions;Journal of Molecular and Cellular Cardiology;2024-03

5. Assessing Tumorigenicity in Stem Cell-Derived Therapeutic Products: A Critical Step in Safeguarding Regenerative Medicine;Bioengineering;2023-07-19